about
Economic and quality of life outcomes of antiretroviral therapy for HIV/AIDS in developing countries: a systematic literature reviewRationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences.Interventions to improve the rate or timing of initiation of antiretroviral therapy for HIV in sub-Saharan Africa: meta-analyses of effectivenessThe impact and cost of scaling up GeneXpert MTB/RIF in South AfricaUptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in ZambiaHow to estimate the cost of point-of-care CD4 testing in program settings: an example using the Alere Pima Analyzer in South AfricaPatient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewDo the socioeconomic impacts of antiretroviral therapy vary by gender? A longitudinal study of Kenyan agricultural worker employment outcomes.A new cascade of HIV care for the era of "treat all".Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review.Economic outcomes of patients receiving antiretroviral therapy for HIV/AIDS in South Africa are sustained through three years on treatment.Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: a cross-sectional study of cost, stigma, and perceptions about ARTImprovements in physical wellbeing over the first two years on antiretroviral therapy in western KenyaEffect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study.Antiretroviral therapy, labor productivity, and sex: a longitudinal cohort study of tea pluckers in Kenya.The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data.Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohortRetention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.Lost opportunities to complete CD4+ lymphocyte testing among patients who tested positive for HIV in South AfricaEarly loss to follow up after enrolment in pre-ART care at a large public clinic in Johannesburg, South AfricaCost of using a patient tracer to reduce loss to follow-up and ascertain patient status in a large antiretroviral therapy program in Johannesburg, South Africa.Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa.Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South AfricaRetention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysisThresholds for the cost-effectiveness of interventions: alternative approaches.Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort studyRetention of Adult Patients on Antiretroviral Therapy in Low- and Middle-Income Countries: Systematic Review and Meta-analysis 2008-2013Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South AfricaThe High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South AfricaInitiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled TrialEarly Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort StudyTreatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa.Rapid point-of-care CD4 testing at mobile HIV testing sites to increase linkage to care: an evaluation of a pilot program in South AfricaScaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa.ART treatment costs and retention in care in Kenya: a cohort study in three rural outpatient clinics.Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa.Defining retention and attrition in pre-antiretroviral HIV care: proposals based on experience in Africa.HIV treatment produces economic returns through increased work and education, and warrants continued US supportSame-Day CD4 Testing to Improve Uptake of HIV Care and Treatment in South Africa: Point-of-Care Is Not EnoughAccelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda
P50
Q22248034-4BA413EC-A949-4B0C-BDB9-794B9641D307Q24814494-6FC7E5DE-498E-41F7-BEC5-D5C0F3C396F7Q26738303-53A0645C-C8BC-4D97-9740-342AEF3D72D1Q28484044-17478862-91B2-4968-8561-82C34EA5C3BEQ28535891-900B7AC2-806D-4773-B497-E5C5A0267273Q28730481-43912989-63F0-486F-83D7-122C9D800556Q33302944-BBAF82BD-3700-4702-9C90-29032FBE45A8Q33482523-7B7FDC2D-2F0F-47D8-BB25-35ED90391C7EQ33554305-678C950B-812D-4D3B-8BEF-BBB1A8F7114FQ33619740-68BAB44A-4911-405E-BD5D-958CD148DF6EQ33697770-38E68FD9-842F-4C8E-94C6-2AB21FB80F63Q33763374-D8B6484C-56AB-4A63-B93D-9CD011B8B1BAQ33795359-470FD44A-A76F-40FB-97BD-FC4A2BD00F66Q33803388-455BE6A5-9E7F-49A0-98C4-F4CDD03021A7Q33831891-D356650E-5280-446E-88AB-6D02CB13988CQ33901360-238D3EBA-1B40-4FD6-8224-7FF1ED815CC4Q33979490-5863FD15-DC0E-4A83-A5C6-DA22B1060C63Q33979497-528FF86C-585D-46A7-BF5D-08C68C340E20Q34092731-A0B2DC5E-39D6-4C4A-A6E9-2B5E7874E766Q34196503-04A3EC66-6179-4937-8E12-EC62CD48FFBFQ34687558-87A25213-CC96-43FF-97AD-D73B0C01BF0FQ34687565-1E01ACFB-76FD-4665-824D-45CB3C324774Q34694783-D343A042-0780-4526-9B20-BC1D6027E44EQ34808183-57A2A7C6-F944-40C2-9154-328076E6411BQ35119997-2BC005AF-8A47-44F2-A8F3-2E3A41AB8BF8Q35135593-20AD2FB0-6F10-4D16-8596-E9688E60ED68Q35576031-E9DCFF9D-344B-4B82-9893-30881E98D08BQ35850330-531B2FBD-B861-4229-B167-18C3705B7413Q35925982-CFB45BE4-9008-448E-B7D3-C4AEE116CE32Q36013294-3A9D3E67-E0F9-4EB5-A197-7A962CEBCF24Q36182135-3B9E7F6D-1DA3-42AD-ADE8-DCFCD17BB38EQ36220031-76C9C08A-DDB8-4594-87A2-12DFCA5978F3Q36279351-6F63878B-52BA-492D-8B2C-F0EE86B7CC7FQ36424212-4272BD46-3995-4FAC-BE1F-A5F06526F4B6Q36508287-E352B393-3B52-41AF-BD42-57D040ACFA34Q36763727-6A953361-30AB-4835-AC47-6287091CE052Q37053825-FFA4B41D-88E0-49D2-8F46-7BB9D4ADB39DQ37057563-A2FE817F-9A56-47E3-A7B7-01630D25980FQ37061972-0B372D69-55ED-4D5D-A246-4DDA7068118AQ37162105-CFE044CA-63CE-4917-B915-3A8954E3D819
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sydney Rosen
@ast
Sydney Rosen
@en
Sydney Rosen
@es
Sydney Rosen
@nl
Sydney Rosen
@sl
type
label
Sydney Rosen
@ast
Sydney Rosen
@en
Sydney Rosen
@es
Sydney Rosen
@nl
Sydney Rosen
@sl
prefLabel
Sydney Rosen
@ast
Sydney Rosen
@en
Sydney Rosen
@es
Sydney Rosen
@nl
Sydney Rosen
@sl
P108
P106
P1153
7401609414
P21
P31
P496
0000-0002-6560-2964